Operational Strategies for Clinical Trials in Africa
Author(s) -
Katy Graef,
Ifeoma Okoye,
Naomi Oyoe Ohene Oti,
Jennifer Dent,
Folakemi T. Odedina
Publication year - 2020
Publication title -
jco global oncology
Language(s) - English
Resource type - Journals
ISSN - 2687-8941
DOI - 10.1200/jgo.19.00204
Subject(s) - clinical trial , summit , blueprint , government (linguistics) , medicine , private sector , capacity building , political science , economic growth , public relations , geography , law , mechanical engineering , linguistics , philosophy , pathology , physical geography , engineering , economics
In a dramatic reversal of longstanding trends, cancer now kills more Africans than malaria. Despite Africa's growing cancer burden, individuals of African descent, notably those residing in Africa, remain drastically under-represented in cancer clinical trials. Two recent summits-the 1st All Africa Clinical Trial Summit and the Operational Strategy for Clinical Trials in Nigeria Summit-convened experts from governments, the private sector, universities, and professional societies to define the barriers to Africa's participation in multicenter clinical studies and the strategies to eliminate those impedances.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom